| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
548 |
440 |
$248K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
441 |
392 |
$131K |
| 87631 |
|
188 |
187 |
$22K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
211 |
73 |
$12K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
387 |
129 |
$11K |
| 80053 |
Comprehensive metabolic panel |
1,041 |
884 |
$8K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,226 |
1,022 |
$8K |
| 87486 |
|
188 |
187 |
$6K |
| 87581 |
|
188 |
187 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
176 |
175 |
$5K |
| 36415 |
Collection of venous blood by venipuncture |
1,865 |
1,512 |
$5K |
| 84443 |
Thyroid stimulating hormone (TSH) |
169 |
166 |
$2K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
52 |
15 |
$1K |
| 81000 |
|
495 |
436 |
$1K |
| 87077 |
|
192 |
172 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
17 |
17 |
$600.34 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
25 |
25 |
$171.48 |
| 80061 |
Lipid panel |
13 |
13 |
$133.92 |
| 87076 |
|
14 |
14 |
$101.85 |
| 84439 |
|
13 |
13 |
$100.20 |
| 87181 |
|
13 |
13 |
$63.11 |
| G0008 |
Administration of influenza virus vaccine |
28 |
28 |
$14.46 |
| Q2038 |
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) |
29 |
29 |
$9.02 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
14 |
12 |
$0.92 |